Delivery Order SPE2DB22D3501-SPE2DB25FTF81

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,495.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a Delivery Order worth $3,583.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of 4,563,755,368 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of February 26, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,060.04 Firm Fixed Price Delivery Order is for the supply of 4,563,337,812 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,707,544 units of Tamsulosin HCL 0.4 mg capsules. The firm-fixed-price, $1,667.08 delivery order contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,899.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,957,151 units of the medication Tamsulosin HCL 0.4 mg Capsule, with a performance period ending on April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,528.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order to supply 4,564,847,146 capsules of the prescription medication Tamsulosin HCL 0.4 mg. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This federal contract award is a delivery order worth $6,657.11 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 1,000 capsules of the prescription drug Tamsulosin HCl 0.4 mg. The contract has a firm-fixed price pricing type and a completion date of September 9, 2024. It is not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,189.17 firm fixed-price delivery order is for the supply of 1,000 units of the prescription drug Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.04 firm fixed-price delivery order contract is for the supply of 4,566,690,189 units of the prescription medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,346.70 firm fixed-price delivery order is for the supply of 4,566,401,620 capsules of the generic drug Tamsulosin HCL 0.4 mg. The award has an ultimate completion date of November 13, 2024 and is not associated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTF81
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,954.40. The contract was awarded by the Defense Logistics Agency (DLA) to provide 4,566,179,279 units of the drug Tamsulosin Hydrochloride 0.4 mg Capsule with an ultimate completion date of October 23, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award falls under that larger IDC framework. The contract has no set-aside designation, indicating open competition.

Generated 1/22/25, 1:01 AM